• Często zadawane pytania
  • Słownik
Więcej

Często zadawane pytania

Why are animal models used when testing the safety of a new therapy?
What role do preclinical and clinical trials play in ensuring patient safety?
Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Zobacz wszystkie często zadawane pytania

Więcej

Słownik

Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising 
Antibody
Antigen
Base editors

Zobacz kompletny słowniczek

CAR (Chimeric Antigen Receptor) T-Cell Therapy

Related topics:
Terapia CAR-T

This program features topics relevant to the multidisciplinary team approach to caring for patients receiving CAR T-cell therapies and their relatives.

CAR (Chimeric Antigen Receptor) T-Cell Therapy

Podziękowania i prawa autorskie

The CAR (Chimeric Antigen Receptor) T-cell therapies: a resource for healthcare professionals learning program was made possible by an educational grant from Celgene / Bristol Myers Squibb Company, Janssen-Cilag AG, Novartis and Kite Gilead.

HNHCP logo
Powrót do góry strony
Czy uważasz informacje na tej stronie za pomocne? Przyślij nam swoje uwagi